1-7 of 7
Ken K. Ong
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The High-Risk Type 1 Diabetes HLA-DR and HLA-DQ Polymorphisms Are Differentially Associated With Growth and IGF-I Levels in Infancy: The Cambridge Baby Growth Study

Antigoni Eleftheriou, Clive J. Petry, Ieuan A. Hughes, Ken K. Ong, David B. Dunger
Journal: Diabetes Care
Diabetes Care 2021;44(8):1852–1859
https://doi.org/10.2337/dc20-2820
Published: 11 August 2021
View article titled, The High-Risk Type 1 Diabetes HLA-DR and HLA-DQ Polymorphisms Are Differentially Associated With Growth and IGF-I Levels in Infancy: The Cambridge Baby Growth Study
Open the PDF for The High-Risk Type 1 Diabetes HLA-DR and HLA-DQ Polymorphisms Are Differentially Associated With Growth and IGF-I Levels in Infancy: The Cambridge Baby Growth Study in another window
Journal Articles

An Unbiased Lipidomics Approach Identifies Early Second Trimester Lipids Predictive of Maternal Glycemic Traits and Gestational Diabetes Mellitus

Liangjian Lu, Albert Koulman, Clive J. Petry, Benjamin Jenkins, Lee Matthews, Ieuan A. Hughes, Carlo L. Acerini, Ken K. Ong, David B. Dunger
Journal: Diabetes Care
Diabetes Care 2016;39(12):2232–2239
https://doi.org/10.2337/dc16-0863
Published: 04 October 2016
View article titled, An Unbiased Lipidomics Approach Identifies Early Second Trimester Lipids Predictive of Maternal Glycemic Traits and Gestational Diabetes Mellitus
Open the PDF for An Unbiased Lipidomics Approach Identifies Early Second Trimester Lipids Predictive of Maternal Glycemic Traits and Gestational Diabetes Mellitus in another window
Includes: Supplementary data
Journal Articles

Age at Menarche and Type 2 Diabetes Risk: The EPIC-InterAct study

Cathy E. Elks, PHD, Ken K. Ong, FRCPCH, Robert A. Scott, PHD, Yvonne T. van der Schouw, PHD, Judith S. Brand, MSC, Petra A. Wark, MSC, Pilar Amiano, MSC, Beverley Balkau, PHD, Aurelio Barricarte, MD, Heiner Boeing, PHD, Ana Fonseca-Nunes, MSC, Paul W. Franks, PHD, Sara Grioni, BSC, Jytte Halkjaer, PHD, Rudolf Kaaks, PHD, Timothy J. Key, DPHIL, Kay Tee Khaw, MBBCHIR, Amalia Mattiello, MD, Peter M. Nilsson, MD, Kim Overvad, PHD, Domenico Palli, MD, J. Ramón Quirós, MD, Sabina Rinaldi, PHD, Olov Rolandsson, MD, Isabelle Romieu, PHD, Carlotta Sacerdote, MD, María-José Sánchez, MD, Annemieke M.W. Spijkerman, PHD, Anne Tjonneland, DRMEDSCI, Maria-Jose Tormo, MD, Rosario Tumino, MD, Daphne L. van der A, PHD, Nita G. Forouhi, PHD, Stephen J. Sharp, MSC, Claudia Langenberg, MD, Elio Riboli, MD, Nicholas J. Wareham, MD, The InterAct Consortium
Journal: Diabetes Care
Diabetes Care 2013;36(11):3526–3534
https://doi.org/10.2337/dc13-0446
Published: 15 October 2013
View article titled, Age at Menarche and Type 2 Diabetes Risk: <subtitle>The EPIC-InterAct study</subtitle>
Open the PDF for Age at Menarche and Type 2 Diabetes Risk: <subtitle>The EPIC-InterAct study</subtitle> in another window
Includes: Supplementary data
Journal Articles

Age at Menopause, Reproductive Life Span, and Type 2 Diabetes Risk: Results from the EPIC-InterAct study

Judith S. Brand, MSC, Yvonne T. van der Schouw, PHD, N. Charlotte Onland-Moret, PHD, Stephen J. Sharp, MSC, Ken K. Ong, PHD, Kay-Tee Khaw, PHD, Eva Ardanaz, PHD, Pilar Amiano, PHD, Heiner Boeing, PHD, Maria-Dolores Chirlaque, MD, Françoise Clavel-Chapelon, PHD, Francesca L. Crowe, PHD, Blandine de Lauzon-Guillain, PHD, Eric J. Duell, PHD, Guy Fagherazzi, PHD, Paul W. Franks, PHD, Sara Grioni, MSC, Leif C. Groop, PHD, Rudolf Kaaks, PHD, Timothy J. Key, PHD, Peter M. Nilsson, MD, Kim Overvad, PHD, Domenico Palli, MD, Salvatore Panico, MD, J. Ramón Quirós, MD, Olov Rolandsson, MD, Carlotta Sacerdote, PHD, María-José Sánchez, MD, Nadia Slimani, PHD, Birgit Teucher, PHD, Anne Tjonneland, PHD, Rosario Tumino, MD, Daphne L. van der A, PHD, Edith J.M. Feskens, PHD, Claudia Langenberg, PHD, Nita G. Forouhi, PHD, Elio Riboli, PHD, Nicholas J. Wareham, PHD, The InterAct Consortium
Journal: Diabetes Care
Diabetes Care 2013;36(4):1012–1019
https://doi.org/10.2337/dc12-1020
Published: 14 March 2013
View article titled, Age at Menopause, Reproductive Life Span, and Type 2 Diabetes Risk: <subtitle>Results from the EPIC-InterAct study</subtitle>
Open the PDF for Age at Menopause, Reproductive Life Span, and Type 2 Diabetes Risk: <subtitle>Results from the EPIC-InterAct study</subtitle> in another window
Includes: Supplementary data
Journal Articles

Pregnancy Insulin, Glucose, and BMI Contribute to Birth Outcomes in Nondiabetic Mothers

Ken K. Ong, PHD, Barbro Diderholm, PHD, Giuseppina Salzano, PHD, Dianne Wingate, BSC, Ieuan A. Hughes, MD, Jane MacDougall, MD, Carlo L. Acerini, MD, David B. Dunger, MD
Journal: Diabetes Care
Diabetes Care 2008;31(11):2193–2197
https://doi.org/10.2337/dc08-1111
Published: 01 November 2008
View article titled, Pregnancy Insulin, Glucose, and BMI Contribute to Birth Outcomes in Nondiabetic Mothers
Open the PDF for Pregnancy Insulin, Glucose, and BMI Contribute to Birth Outcomes in Nondiabetic Mothers in another window
Journal Articles

Genetics of Size at Birth

David B. Dunger, MD, FRCP, FRCPCH, Clive J. Petry, PHD, Ken K. Ong, MD, PHD, MRCP, MRCPCH
Journal: Diabetes Care
Diabetes Care 2007;30(Supplement_2):S150–S155
https://doi.org/10.2337/dc07-s208
Published: 01 July 2007
View article titled, Genetics of Size at Birth
Open the PDF for Genetics of Size at Birth in another window
Journal Articles

Randomized Cross-Over Trial of Insulin Glargine Plus Lispro or NPH Insulin Plus Regular Human Insulin in Adolescents With Type 1 Diabetes on Intensive Insulin Regimens

Nuala P. Murphy, MRCPI, Suzanne M. Keane, MRCPCH, Ken K. Ong, MRCPCH, Martha Ford-Adams, MRCPCH, Julie A. Edge, MD, Carlo L. Acerini, MD, David B. Dunger, MD
Journal: Diabetes Care
Diabetes Care 2003;26(3):799–804
https://doi.org/10.2337/diacare.26.3.799
Published: 01 March 2003
View article titled, Randomized Cross-Over Trial of Insulin Glargine Plus Lispro or NPH Insulin Plus Regular Human Insulin in Adolescents With Type 1 Diabetes on Intensive Insulin Regimens
Open the PDF for Randomized Cross-Over Trial of Insulin Glargine Plus Lispro or NPH Insulin Plus Regular Human Insulin in Adolescents With Type 1 Diabetes on Intensive Insulin Regimens in another window